Ankylosing Spondylitis Market
The 2021 valuation for the global Ankylosing Spondylitis (AS) market reached USD 4.2 billion, with an anticipated Compound Annual Growth Rate (CAGR) of 5.8% throughout the forecast period. The main drivers for market revenue expansion include the growing prevalence of AS, heightened awareness about the disease, and an increased demand for effective treatment options.